HSP90AB1 and idiopathic pulmonary fibrosis: Furthermore, as HSP90 inhibitors were shown to modulate several MAP kinases involved in inflammation, cell proliferation and fibrogenesis, further studies are needed to define in particular these pathways in IPF.